Meridian Bioscience reported $31.49M in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4423M 520M
Accelerate Diagnostics AXDX:US 2.14M 391K
Atrion ATRI:US 25.06M 239K
Becton, Dickinson and BDX:US $ 2881M 152M
Bio Rad Laboratories BIO:US $ 305.49M 7.74M
Cerus CERS:US $ 17.58M 2.26M
Genmark Diagnostics GNMK:US $ 30.68M 4.58M
Luminex LMNX:US $ 44.23M 2.72M
Meridian Bioscience VIVO:US $ 31.49M 5.09M
Myriad Genetics MYGN:US $ 47.8M 5.9M
Neogen NEOG:US $ 69.92M 1.63M
Orasure Technologies OSUR:US $ 32.45M 5.52M
Oxford Immunotec Global OXFD:US $ 4.58M 2.41M
Quidel QDEL:US $ 136.33M 65.9M
Rockwell Medical RMTI:US $ 16.32M 0.92M
Sientra SIEN:US $ 9.03M 192K
Staar Surgical STAA:US $ 13.05M 0.11M
Thermo Fisher Scientific TMO:US $ 4533M 216M
Trinity Biotech TRIB:US $ 13.1M 1.71M